FDA Inspection 730893 — ImpactLife

ImpactLife — FEI 3005692903

The FDA completed an inspection of ImpactLife on June 22, 2011 in Cedar Rapids, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 22, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Cedar Rapids, IA (United States)